The Experimental TASK-1 Potassium Channel Inhibitor A293 Can Be Employed for Rhythm Control of Persistent Atrial Fibrillation in a Translational Large Animal Model
出版年份 2021 全文链接
标题
The Experimental TASK-1 Potassium Channel Inhibitor A293 Can Be Employed for Rhythm Control of Persistent Atrial Fibrillation in a Translational Large Animal Model
作者
关键词
-
出版物
Frontiers in Physiology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-01-21
DOI
10.3389/fphys.2020.629421
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A lower X-gate in TASK channels traps inhibitors within the vestibule
- (2020) Karin E. J. Rödström et al. NATURE
- Pharmacologic TWIK‐Related Acid‐Sensitive K+ Channel (TASK‐1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model
- (2020) Felix Wiedmann et al. Journal of the American Heart Association
- Mechanosensitive TREK-1 two-pore-domain potassium (K2P) channels in the cardiovascular system
- (2020) Felix Wiedmann et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
- (2020) Gerhard Hindricks et al. EUROPEAN HEART JOURNAL
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Atria-selective antiarrhythmic drugs in need of alliance partners
- (2019) Rémi Peyronnet et al. PHARMACOLOGICAL RESEARCH
- Effects of the ventilatory stimulant, doxapram on human TASK‐3 (KCNK9, K2P9.1) channels and TASK‐1 (KCNK3, K2P3.1) channels
- (2019) Kevin P. Cunningham et al. Acta Physiologica
- Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K + Channel–Related Acid-Sensitive K + Channel-1) (K 2P 3.1) K + Channels Suppresses Atrial Fibrillation and Prevents Electrical Remodeling
- (2019) Constanze Schmidt et al. Circulation-Arrhythmia and Electrophysiology
- TASK-1 potassium channel is not critically involved in mediating hypoxic pulmonary vasoconstriction of murine intra-pulmonary arteries
- (2017) Ghulam Murtaza et al. PLoS One
- Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial HypertensionCLINICAL PERSPECTIVE
- (2016) Fabrice Antigny et al. CIRCULATION
- Upregulation of K2P3.1 K+Current Causes Action Potential Shortening in Patients With Chronic Atrial FibrillationCLINICAL PERSPECTIVE
- (2015) Constanze Schmidt et al. CIRCULATION
- TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes
- (2015) Susanne Rinné et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cloning, functional characterization, and remodeling of K2P3.1 (TASK-1) potassium channels in a porcine model of atrial fibrillation and heart failure
- (2014) Constanze Schmidt et al. HEART RHYTHM
- Kv1.5 blockers preferentially inhibit TASK-1 channels: TASK-1 as a target against atrial fibrillation and obstructive sleep apnea?
- (2014) Aytug K. Kiper et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- TASK-1 (KCNK3) and TASK-3 (KCNK9) Tandem Pore Potassium Channel Antagonists Stimulate Breathing in Isoflurane-Anesthetized Rats
- (2013) Joseph F. Cotten ANESTHESIA AND ANALGESIA
- Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K+ (K2P) channels
- (2013) Constanze Schmidt et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A Novel Channelopathy in Pulmonary Arterial Hypertension
- (2013) Lijiang Ma et al. NEW ENGLAND JOURNAL OF MEDICINE
- The TASK1 channel inhibitor A293 shows efficacy in a mouse model of multiple sclerosis
- (2012) Stefan Bittner et al. EXPERIMENTAL NEUROLOGY
- TASK-1 Channels May Modulate Action Potential Duration of Human Atrial Cardiomyocytes
- (2011) Sven H. Limberg et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Disruption of K 2P 6.1 Produces Vascular Dysfunction and Hypertension in Mice
- (2011) Eric E. Lloyd et al. HYPERTENSION
- Pathophysiological Mechanisms of Atrial Fibrillation: A Translational Appraisal
- (2011) Ulrich Schotten et al. PHYSIOLOGICAL REVIEWS
- Characterization of Human Cardiac Kv1.5 Inhibition by the Novel Atrial-selective Antiarrhythmic Compound AVE1231
- (2009) Joachim R Ehrlich et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Atrial Remodeling and Atrial Fibrillation
- (2008) Stanley Nattel et al. Circulation-Arrhythmia and Electrophysiology
- Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact
- (2008) Douglas A. Bayliss et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started